GANX
Gain Therapeutics Inc.
$1.96
+$0.20(+11.36%)
54
Overall
40
Value
91
Tech
31
Quality
Market Cap
$56.80M
Volume
1.14M
52W Range
$1.41 - $2.81
Target Price
$7.43
EPS Estimates Overview
| Current Quarter | $-0.15 | Next Quarter | $-0.16 |
| Current Year | $-0.67 | Next Year | $-0.73 |
| QoQ Growth | -6.7% | YoY Growth | -9.0% |
| 3Y EPS CAGR | +13.4% | Target Price | $7.43 |
| Consensus | Buy | Upside | +279.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.96 | +11.4% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |